Is It Too Late to Buy Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals (NASDAQ: VRTX) did something most other biotech companies didn’t last year: It beat the bear market. The specialist in treatments for cystic fibrosis (CF) climbed as the three major indexes dipped into bear territory. And it finished the year with a 31% gai

admin